What is WESTERN URANIUM&VANADIUM's earnings per share (EPS)?

WESTERN URANIUM&VANADIUM (WSTRF) reported diluted earnings per share of -$0.11 for fiscal year 2025. This represents a 38.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

WESTERN URANIUM&VANADIUM (WSTRF) Financials

WSTRF

Trailing 12 months to June 30, 2026

Revenue $581K +259.5% YoY

Net Income -$5.3M +44.5% YoY

EPS (Diluted) -$0.08 +46.7% YoY

Operating Cash Flow -$4.4M +45.8% YoY

Market Cap $24.1M as of Oct 16, 2026

Price / Sales 41.6x on $581K revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 0.9x on $27.8M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 16, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 14, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the WSTRF SEC filings page.

WESTERN URANIUM&VANADIUM (WSTRF) reported $581K in revenue over the twelve months to Jun 30, 2026, up 259.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI WSTRF FY2025 2026-10-03

Western Uranium remains asset-heavy, with reported revenue too small to fund operations and new financing supporting the balance sheet.

The FY2025 revenue rebound to $425K did not restore operating economics: operating loss was $7.3M, while operating cash flow remained negative at -$5.8M. Financing provided $7.1M, while shares outstanding rose from 59.4M to 71.9M, linking balance-sheet support to equity issuance rather than internally generated cash.

The balance sheet is not being scaled by sales: FY2025 assets were $34.4M against $425K of revenue. At roughly 81.0x assets-to-revenue and 0.1x debt-to-equity, the structure is more equity-led than debt-led.

Reported liquidity equaled 11.7 months of the latest annual operating outflow, while the current ratio was 8.1x, indicating modest short-term obligations relative to current assets. That liquidity comparison coexists with negative operating cash flow and $7.1M of FY2025 financing, showing that balance-sheet capacity did not eliminate external funding needs.

Financial Health Signals

Financial health score not available

WESTERN URANIUM&VANADIUM does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

1.53

WESTERN URANIUM&VANADIUM scores 1.53, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($24.1M) relative to total liabilities ($4.1M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

4/7

WESTERN URANIUM&VANADIUM passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing

N/A

WESTERN URANIUM&VANADIUM reported a net loss of $7.2M while operations used $5.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$200K

YoY+554.0%

QoQ+629.5%

5Y CAGR+65.3%

WESTERN URANIUM&VANADIUM generated $200K in revenue in Q2 2026. This represents an increase of 554.0% from the same quarter a year earlier. Against the prior quarter it is up 629.5%.

EBITDA

-$1.0M

YoY+43.6%

QoQ+29.1%

WESTERN URANIUM&VANADIUM's EBITDA was -$1.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 43.6% from the same quarter a year earlier. Against the prior quarter it is up 29.1%.

Net Income

-$1.2M

YoY+41.0%

QoQ+27.4%

WESTERN URANIUM&VANADIUM reported -$1.2M in net income in Q2 2026. This represents an increase of 41.0% from the same quarter a year earlier. Against the prior quarter it is up 27.4%.

EPS (Diluted)

-$0.02

YoY+33.3%

QoQ0.0%

WESTERN URANIUM&VANADIUM earned -$0.02 per diluted share (EPS) in Q2 2026. This represents an increase of 33.3% from the same quarter a year earlier. It is unchanged from the prior quarter.

Cash & Balance Sheet

Cash & Debt

$3.5M

YoY-20.8%

QoQ-22.7%

5Y CAGR-7.8%

10Y CAGR+66.0%

WESTERN URANIUM&VANADIUM held $3.5M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

72M

YoY+10.0%

QoQ0.0%

5Y CAGR+13.5%

10Y CAGR+15.6%

WESTERN URANIUM&VANADIUM had 72M shares outstanding in Q2 2026. This represents an increase of 10.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Return on Equity

-4.2%

YoY+2.6pp

QoQ+1.4pp

5Y change-2.2pp

WESTERN URANIUM&VANADIUM's ROE was -4.2% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 2.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.4 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

None of these metrics is reported for Q2 2026.

WSTRF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

WSTRF quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Revenue	$581K	$425K+131.5%	$184K-57.4%	$431K-94.5%	$7.9M+2787.8%	$272K+398.2%	$55K+22.4%	$45K-7.5%	$48K+141.2%	$20K	$0	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	$4.0M0.0%	$4.0M	N/A	N/A	$20K+128.3%	$9K	N/A	N/A
Gross Profit	N/A	N/A	N/A	$431K-88.7%	$3.8M+201.1%	-$3.8M	N/A	N/A	$28K+151.2%	$11K	N/A	N/A
SG&A Expenses	$2.2M	$2.3M-36.6%	$3.6M+91.0%	$1.9M-41.9%	$3.2M+176.8%	$1.2M+3.2%	$1.1M+1.2%	$1.1M-10.4%	$1.3M+73.1%	$723K+32.3%	$547K+35.3%	$404K
Operating Income	-$5.5M	-$7.3M+29.5%	-$10.3M-102.8%	-$5.1M-554.0%	-$779K+61.3%	-$2.0M-11.0%	-$1.8M+11.3%	-$2.0M-1.8%	-$2.0M-17.5%	-$1.7M+8.7%	-$1.9M-27.1%	-$1.5M
EBITDA	N/A	-$6.5M+33.5%	-$9.7M-101.1%	-$4.8M-542.4%	-$752K+62.2%	-$2.0M-10.5%	-$1.8M+11.5%	-$2.0M	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	$13K-79.6%	$65K+80.9%	$36K-40.0%	$60K-80.1%	$302K+163.4%	$115K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$1.4M	N/A	N/A
Net Income	-$5.3M	-$7.2M+29.0%	-$10.1M-104.6%	-$4.9M-592.5%	-$714K+65.6%	-$2.1M+13.3%	-$2.4M-13.4%	-$2.1M-3.2%	-$2.0M-393.4%	-$414K+80.9%	-$2.2M-36.9%	-$1.6M
EPS (Basic)	N/A	-$0.11+38.9%	-$0.18-63.6%	-$0.11-450.0%	-$0.02+66.7%	-$0.06+25.0%	-$0.08	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	-$0.08	-$0.11+38.9%	-$0.18-63.6%	-$0.11-450.0%	-$0.02+66.7%	-$0.06	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	64M+16.3%	55M+25.0%	44M+2.9%	43M+16.2%	37M	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$200K+554.0%	$27K-33.6%	$25K-31.1%	$328K+519.8%	$31K-23.3%	$41K-24.0%	$37K-49.7%	$53K-40.6%
SG&A Expenses	$495K-9.3%	$673K-8.0%	$487K-51.1%	$519K-36.2%	$545K-33.9%	$732K-24.2%	$995K+98.9%	$813K+122.7%
Operating Income	-$1.2M+38.6%	-$1.6M+38.9%	-$1.5M+47.5%	-$1.2M+49.1%	-$2.0M+27.0%	-$2.7M-5.6%	-$2.8M-62.0%	-$2.3M-109.3%
EBITDA	-$1.0M+43.6%	-$1.4M+42.9%	-$1.3M+52.0%	-$962K+54.9%	-$1.8M+30.7%	-$2.5M-2.4%	-$2.6M-60.8%	-$2.1M-106.3%
Net Income	-$1.2M+41.0%	-$1.6M+39.3%	-$1.4M+47.7%	-$1.1M+49.9%	-$2.0M+25.0%	-$2.6M-6.5%	-$2.8M-62.6%	-$2.2M-111.4%
EPS (Basic)	-$0.02+33.3%	-$0.02+50.0%	-$0.02+50.0%	-$0.02+50.0%	-$0.03+40.0%	-$0.04+20.0%	-$0.040.0%	-$0.04-100.0%
EPS (Diluted)	-$0.02+33.3%	-$0.02+50.0%	-$0.02+50.0%	-$0.02+50.0%	-$0.03+40.0%	-$0.04+20.0%	-$0.04	-$0.04-100.0%
Diluted Shares (Avg)	72M+18.8%	72M+21.0%	N/A	65M+18.2%	61M+9.6%	59M+13.0%	N/A	55M+26.6%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Interest Expense, Income Tax.

WSTRF Balance Sheet

WSTRF quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Total Assets	$34.4M+1.6%	$33.9M-2.8%	$34.9M+5.1%	$33.2M+21.2%	$27.4M+19.9%	$22.8M-6.5%	$24.4M+5.3%	$23.2M+2.5%	$22.6M-1.9%	$23.1M-2.1%	$23.6M
Current Assets	$6.1M+2.7%	$6.0M-38.9%	$9.8M-4.2%	$10.2M+87.5%	$5.5M+590.6%	$791K-66.7%	$2.4M+109.4%	$1.1M+65.7%	$685K-38.5%	$1.1M+215.6%	$353K
Cash & Equivalents	$5.6M+2.5%	$5.5M-40.5%	$9.2M-4.8%	$9.7M+999.2%	$881K+55.8%	$565K-72.9%	$2.1M+129.1%	$910K+113.1%	$427K-46.1%	$792K+269.2%	$214K
Short-Term Investments	$0	$0-100.0%	$385-37.1%	$612-71.1%	$2K-11.9%	$2K-12.8%	$3K-42.3%	$5K+53.1%	$3K+4.9%	$3K+3.3%	$3K
Inventory	N/A	N/A	N/A	N/A	$4.1M	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$4.1M+1.1%	$4.1M-0.7%	$4.1M+4.6%	$3.9M-8.2%	$4.3M+5.5%	$4.1M+1.8%	$4.0M+3.4%	$3.9M-13.7%	$4.5M-28.4%	$6.3M-19.7%	$7.8M
Current Liabilities	$762K+2.1%	$747K-10.7%	$836K+24.7%	$671K-30.8%	$969K+54.2%	$628K-10.1%	$699K+29.9%	$538K-52.4%	$1.1M-3.4%	$1.2M-61.9%	$3.1M
Non-Current Liabilities	$3.4M+0.9%	$3.4M+1.9%	$3.3M+0.5%	$3.3M-1.6%	$3.3M-3.4%	$3.4M+4.3%	$3.3M-0.9%	$3.3M-0.7%	$3.4M-34.1%	$5.1M+7.6%	$4.7M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$487K-25.2%	$651K-30.7%	$940K
Total Equity	$30.3M+1.6%	$29.8M-3.1%	$30.8M+5.2%	$29.3M+26.7%	$23.1M+23.0%	$18.8M-8.1%	$20.4M+5.7%	$19.3M+6.4%	$18.2M+8.0%	$16.8M+6.5%	$15.8M
Retained Earnings	-$36.1M-24.8%	-$28.9M-53.7%	-$18.8M-35.6%	-$13.9M-5.4%	-$13.2M-18.7%	-$11.1M-27.5%	-$8.7M-32.0%	-$6.6M-45.0%	-$4.5M-10.0%	-$4.1M-111.4%	-$2.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$31.9M-3.7%	$33.1M+5.2%	$34.4M+1.6%	$32.0M-2.8%	$33.1M-5.2%	$31.5M-15.7%	$33.9M-2.8%	$32.9M+6.7%
Current Assets	$4.1M-14.9%	$5.0M+55.6%	$6.1M+2.7%	$3.9M-44.8%	$4.8M-46.9%	$3.2M-73.0%	$6.0M-38.9%	$7.0M+13.4%
Cash & Equivalents	$3.5M-20.8%	$4.6M+64.2%	$5.6M+2.5%	$3.2M-52.0%	$4.4M-49.6%	$2.8M-75.9%	$5.5M-40.5%	$6.6M+14.4%
Short-Term Investments	$0	$0	$0	$0	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$4.1M-3.3%	$4.2M+3.9%	$4.1M+1.1%	$4.1M-1.1%	$4.2M+1.7%	$4.0M-1.0%	$4.1M-0.7%	$4.2M+6.0%
Current Liabilities	$665K-19.4%	$809K+17.7%	$762K+2.1%	$737K-12.1%	$824K-2.5%	$688K-15.0%	$747K-10.7%	$838K+28.4%
Non-Current Liabilities	$3.4M+0.6%	$3.4M+1.1%	$3.4M+0.9%	$3.4M+1.7%	$3.4M+2.8%	$3.4M+2.5%	$3.4M+1.9%	$3.3M+1.5%
Total Equity	$27.8M-3.8%	$28.9M+5.4%	$30.3M+1.6%	$27.9M-3.0%	$28.9M-6.1%	$27.4M-17.5%	$29.8M-3.1%	$28.8M+6.7%
Retained Earnings	-$38.9M-15.9%	-$37.7M-19.4%	-$36.1M-24.8%	-$34.7M-32.5%	-$33.5M-40.2%	-$31.6M-48.2%	-$28.9M-53.7%	-$26.2M-52.9%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

WSTRF Cash Flow Statement

WSTRF quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Operating Cash Flow	-$4.4M	-$5.8M+30.4%	-$8.3M-102.9%	-$4.1M-189.9%	$4.6M+173.9%	-$6.2M-306.6%	-$1.5M+15.2%	-$1.8M-8.5%	-$1.6M+1.2%	-$1.7M+14.0%	-$1.9M-61.6%	-$1.2M
Depreciation & Amortization	N/A	$823K+34.1%	$614K+133.5%	$263K+877.9%	$27K+31.9%	$20K+91.8%	$11K+60.7%	$7K	N/A	N/A	N/A	N/A
Stock-Based Compensation	N/A	$558K-51.1%	$1.1M+166.1%	$429K-72.6%	$1.6M	N/A	$205K+13.6%	$180K-56.0%	$410K+95.8%	$209K+37.5%	$152K	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	$1.0M+1508.7%	$65K	N/A	$71K+94.6%	$37K	N/A	N/A	$20K
Free Cash Flow	N/A	N/A	N/A	N/A	$3.5M+156.3%	-$6.2M	N/A	-$1.9M-10.3%	-$1.7M	N/A	N/A	-$1.2M
Investing Cash Flow	-$288K	-$765K+77.4%	-$3.4M-41.1%	-$2.4M-129.9%	-$1.0M-1508.7%	-$65K	N/A	-$71K-94.6%	-$37K+83.1%	-$216K	N/A	-$379K
Financing Cash Flow	N/A	$7.1M-12.4%	$8.2M+39.5%	$5.8M+3.8%	$5.6M-10.7%	$6.3M+8528.9%	$73K-97.6%	$3.0M+32.3%	$2.3M+77.0%	$1.3M-49.8%	$2.6M+64.7%	$1.5M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$1.1M+18.4%	-$1.0M+52.3%	-$993K+60.8%	-$1.2M+38.3%	-$1.4M+32.1%	-$2.2M-24.4%	-$2.5M-66.0%	-$2.0M-73.7%
Depreciation & Amortization	$214K+4.9%	$219K+11.7%	$212K+17.5%	$210K+24.5%	$204K+35.1%	$196K+73.3%	$180K+81.2%	$169K+156.2%
Stock-Based Compensation	N/A	$238K-12.2%	N/A	$89K-40.0%	$150K-34.3%	$271K-47.5%	N/A	$149K
Investing Cash Flow	$102K+148.7%	-$1K+99.4%	-$390K+82.4%	$1K+100.8%	-$210K+66.5%	-$167K+58.7%	-$2.2M-317.3%	-$149K+4.2%
Financing Cash Flow	N/A	N/A	$3.8M+7.3%	$0	N/A	N/A	$3.5M-33.0%	$0

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

WSTRF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

WSTRF quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Gross Margin	N/A	N/A	100.0%+51.5pp	48.5%	-1386.0%	N/A	N/A	58.8%+2.3pp	56.5%	N/A	N/A
Operating Margin	-1712.5%	-5622.8%	-1182.2%	-9.9%	-739.7%	-3320.5%	-4582.9%	-4162.2%	-8542.5%	N/A	N/A
Net Margin	-1686.7%	-5501.6%	-1146.6%	-9.1%	-762.1%	-4381.0%	-4729.3%	-4237.1%	-2071.4%	N/A	N/A
Return on Equity	-23.7%+10.2pp	-33.9%-17.9pp	-16.1%-13.6pp	-2.4%+6.5pp	-9.0%+3.8pp	-12.8%-2.4pp	-10.3%+0.3pp	-10.6%-8.3pp	-2.3%+10.7pp	-12.9%-2.9pp	-10.1%
Return on Assets	-20.8%+9.0pp	-29.8%-15.6pp	-14.2%-12.0pp	-2.1%+5.4pp	-7.6%+2.9pp	-10.5%-1.8pp	-8.6%+0.2pp	-8.8%-7.0pp	-1.8%+7.6pp	-9.4%-2.7pp	-6.7%
Current Ratio	8.060.0x	8.01-3.7x	11.73-3.5x	15.27+9.6x	5.63+4.4x	1.26-2.1x	3.40+1.3x	2.11+1.5x	0.61-0.3x	0.95+0.8x	0.12
Debt-to-Equity	0.140.0x	0.140.0x	0.130.0x	0.13-0.1x	0.190.0x	0.220.0x	0.200.0x	0.20+0.2x	0.030.0x	0.040.0x	0.06
Asset Turnover	0.010.0x	0.010.0x	0.01-0.2x	0.24+0.2x	0.010.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.00	N/A
FCF Margin	N/A	N/A	N/A	44.6%	-2285.5%	N/A	-4158.6%	-3485.9%	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Margin	-608.6%	-5961.5%	-5791.2%	-356.8%	-6485.6%	-6474.3%	-7599.0%	-4344.3%
Net Margin	-582.3%	-5852.9%	-5714.2%	-341.8%	-6452.3%	-6398.7%	-7529.5%	-4230.1%
Return on Equity	-4.2%+2.6pp	-5.5%+4.1pp	-4.8%+4.5pp	-4.0%+3.8pp	-6.8%+1.7pp	-9.6%-2.2pp	-9.3%-3.8pp	-7.8%-3.9pp
Return on Assets	-3.6%+2.3pp	-4.8%+3.5pp	-4.2%+4.0pp	-3.5%+3.3pp	-5.9%+1.6pp	-8.4%-1.8pp	-8.2%-3.3pp	-6.8%-3.4pp
Current Ratio	6.19+0.3x	6.23+1.5x	8.060.0x	5.26-3.1x	5.87-4.9x	4.72-10.1x	8.01-3.7x	8.36-1.1x
Debt-to-Equity	0.150.0x	0.150.0x	0.140.0x	0.150.0x	0.150.0x	0.150.0x	0.140.0x	0.140.0x
Asset Turnover	0.010.0x	0.000.0x	0.000.0x	0.010.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x

Not reported in any period shown, so not listed: Gross Margin, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Where WESTERN URANIUM&VANADIUM Ranks

Frequently Asked Questions

What is WESTERN URANIUM&VANADIUM's annual revenue?

WESTERN URANIUM&VANADIUM (WSTRF) reported $425K in total revenue for fiscal year 2025. This represents a 131.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is WESTERN URANIUM&VANADIUM's revenue growing?

WESTERN URANIUM&VANADIUM (WSTRF) revenue grew by 131.5% year-over-year, from $184K to $425K in fiscal year 2025.

Is WESTERN URANIUM&VANADIUM profitable?

No, WESTERN URANIUM&VANADIUM (WSTRF) reported a net income of -$7.2M in fiscal year 2025.

What is WESTERN URANIUM&VANADIUM's EBITDA?

WESTERN URANIUM&VANADIUM (WSTRF) had EBITDA of -$6.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is WESTERN URANIUM&VANADIUM's return on equity (ROE)?

WESTERN URANIUM&VANADIUM (WSTRF) has a return on equity of -23.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is WESTERN URANIUM&VANADIUM's operating cash flow?

WESTERN URANIUM&VANADIUM (WSTRF) recorded an outflow of $5.8M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are WESTERN URANIUM&VANADIUM's total assets?

WESTERN URANIUM&VANADIUM (WSTRF) had $34.4M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does WESTERN URANIUM&VANADIUM have outstanding?

WESTERN URANIUM&VANADIUM (WSTRF) had 72M shares outstanding as of fiscal year 2025.

What is WESTERN URANIUM&VANADIUM's current ratio?

WESTERN URANIUM&VANADIUM (WSTRF) had a current ratio of 8.06 as of fiscal year 2025, which is generally considered healthy.

What is WESTERN URANIUM&VANADIUM's debt-to-equity ratio?

WESTERN URANIUM&VANADIUM (WSTRF) had a debt-to-equity ratio of 0.14 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is WESTERN URANIUM&VANADIUM's return on assets (ROA)?

WESTERN URANIUM&VANADIUM (WSTRF) had a return on assets of -20.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is WESTERN URANIUM&VANADIUM's P/E ratio?

WESTERN URANIUM&VANADIUM (WSTRF) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $24.1M as of Oct 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is WESTERN URANIUM&VANADIUM's price-to-sales ratio?

WESTERN URANIUM&VANADIUM (WSTRF) trades at 41.6x sales, its market capitalization divided by revenue of $581K revenue, trailing 12 months to June 30, 2026. The market capitalization is $24.1M as of Oct 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does WESTERN URANIUM&VANADIUM's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, WESTERN URANIUM&VANADIUM (WSTRF) held $5.6M in cash, cash equivalents and investments, and reported an operating cash outflow of $5.8M over that year. Dividing the one by the other, the reported balance equals about 12 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is WESTERN URANIUM&VANADIUM's Altman Z-Score?

WESTERN URANIUM&VANADIUM (WSTRF) has an Altman Z-Score of 1.53, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is WESTERN URANIUM&VANADIUM's Piotroski F-Score?

WESTERN URANIUM&VANADIUM (WSTRF) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are WESTERN URANIUM&VANADIUM's earnings high quality?

WESTERN URANIUM&VANADIUM (WSTRF) reported a net loss of $7.2M while operations used $5.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.